Conditions: Psychosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 122
Healthy volunteers: no

Brief summary:
This study evaluates the safety and tolerability of Asenapine in elderly patients with psychosis.

Detailed description:

Arms:
arm 1: Dose titration from 2 mg to 5 mg to 10 mg twice daily (BID) arm 2: Dose titration from 5 mg to 10 mg BID

Interventions: intervention 1: Asenapine
Intervention descriptions: intervention 1: Asenapine 2 mg twice daily (BID) on Days 1 and 2, 5 mg BID on Days 3 and 4, followed by 10 mg BID on Day 5 through the end of the trial (Week 6); or Asenapine 5 mg BID on Days 1 to 4 followed by 10 mg BID on Day 5 through the end of the trial (Week 6).

Protocol document: